ClinicalTrials.Veeva

Menu

Abdominal Drainage in the Postoperative Period of Liver Transplantation (DRALIT)

V

Virgen de la Arrixaca University Clinical Hospital (HCUVA)

Status

Not yet enrolling

Conditions

Liver Transplant; Complications
Drainage

Treatments

Procedure: Abdominal drainage

Study type

Interventional

Funder types

Other

Identifiers

NCT05688137
2022-3-9-HCUVA

Details and patient eligibility

About

Classically, in the postoperative period of liver transplantation (LT), abdominal drainage has been used as a way to make the early diagnosis of hemorrhages, bile leaks and other postsurgical complications, as well as an evacuation route for ascites. The use of it routinely is currently under discussion due to the morbidities associated with its use.

Full description

LT has become in recent years a procedure with an increasing number of indications and with a greater number of donations given the social knowledge of the donation process and donation in controlled asystole. The Spanish Registry of Liver Transplantation (RETH) shows a total of 28,609 TH in the period 1986-2019, which represents an average of 867 TH per year in Spain. These data place Spain among the first countries in terms of HT.

In LT, abdominal drainage has historically been used prophylactically as a way to identify early intra-abdominal postoperative complications such as hemorrhage, bile leakage, and others.

In transplant patients, the use of post-surgical abdominal drains on a routine basis has shown an increase in total protein losses in patients with refractory ascites, an increase in ascending infections secondary to drainage, infection and pain at the insertion point of the drain, as well as as, an increase in hospital stay. Nor can a higher rate of postsurgical bleeding and bile leakage be ruled out in patients with abdominal drainage.

Currently, in the few studies that there are in reference to the systematic use of abdominal drains in lTH, the need for them prophylactically is being discussed as an early diagnosis of postoperative intra-abdominal complications is not observed, but complications are seen to increase secondary to drainage. Therefore, the need to use it systematically in all patients is currently under discussion.

Currently, is facing an increase in ERASⓇ (Enhanced Recovery After Surgey) programs, which began in 2008 with colorectal surgery and are currently expanding to other surgical procedures. These programs advocate reducing the number of drains and even not using them in patients with a low risk of post-surgical complications.

In the current bibliography, the methodology of the studies is varied, with the majority being non-randomized retrospective studies, which is why it is a subject that requires studies with a better methodological design and a higher number of patients to obtain conclusions of clinical relevance. that can set the direction in this area that is in constant discussion.

Given the absence of any randomized non-inferiority clinical trial that studies the routine use of abdominal drainage in the postoperative period of liver transplantation, consider that it is necessary to carry it out to increase the evidence.

The number of HT performed in each center is limited and variable annually, which is why consider that the best design for this clinical trial is a European multicenter.

Enrollment

365 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of both sexes aged between 18 and 75 years included in the waiting list for HT by the committee of the Virgen de la Arrixaca University Hospital.
  • Sign Informed Consent.

Exclusion criteria

  • Having been rejected for liver transplantation by said committee.
  • Age less than 18 years or greater than 75.
  • Any contraindication by the main surgeon that makes the placement of an intra-abdominal drain necessary.
  • Not having signed the Informed Consent.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

365 participants in 2 patient groups

DRAINAGE GROUP (D)
Active Comparator group
Description:
This patients will take the abdominal drainage.
Treatment:
Procedure: Abdominal drainage
NON DRAINAGE GROUP (ND)
No Intervention group
Description:
This patients will not take the abdominal drainage.

Trial documents
2

Trial contacts and locations

0

Loading...

Central trial contact

Álvaro F Cerezuela Fernández de Palencia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems